Abstract: Among saccharides, the antibiotics of the aminoglycoside family are the best-studied class of molecules interacting with RNA. By binding to RNA targets, aminoglycosides act as inhibitors of protein biosynthesis, they interfere with protein–RNA interaction of retroviral regu-latory elements, and they inhibit the catalytic action of ribozymes. Here, we survey the available data on molecular structural details of aminoglycoside–RNA interaction. © 1999 John Wiley &
Jury : Pr Bernard EHRESMANN (Président et examinateur), Dr Jean-Pierre GUILLOTEAU (Rapporteur extern...
AbstractBackground: Aminoglycoside antibiotics bind to the A-site of the decoding region of 16S RNA ...
AbstractBackground: Aminoglycoside antibiotics can target RNA folds with micromolar affinity and inh...
Background: Aminoglycoside antibiotics are known to target ribosomal, retroviral and catalytic RNAs ...
AbstractBackground: Aminoglycoside antibiotics interfere with ribosomal protein synthesis and with i...
Abstract: RNA is increasingly recognized for its signifi cant functions in biological systems and ha...
AbstractBackground: Aminoglycoside antibiotics bind to the A-site of the decoding region of 16S RNA ...
AbstractAminoglycoside antibiotics inhibit protein biosynthesis and various ribozymes. Structural el...
A variety of drugs inhibit biological key processes by binding to a speci®c RNA component. We focus ...
AbstractBackground: Aminoglycoside antibiotics interfere with ribosomal protein synthesis and with i...
AbstractAminoglycoside antibiotics inhibit protein biosynthesis and various ribozymes. Structural el...
The increased awareness of the central role of RNA has led to realization that RNA, as structural an...
AbstractBackground: Aminoglycoside antibiotics can target RNA folds with micromolar affinity and inh...
The codon-anticodon interaction on the ribosome occurs in the A site of the 30 S subunit. Aminoglyco...
Abstract Aminoglycoside antibiotics are protein synthesis inhibitors applied to treat infections cau...
Jury : Pr Bernard EHRESMANN (Président et examinateur), Dr Jean-Pierre GUILLOTEAU (Rapporteur extern...
AbstractBackground: Aminoglycoside antibiotics bind to the A-site of the decoding region of 16S RNA ...
AbstractBackground: Aminoglycoside antibiotics can target RNA folds with micromolar affinity and inh...
Background: Aminoglycoside antibiotics are known to target ribosomal, retroviral and catalytic RNAs ...
AbstractBackground: Aminoglycoside antibiotics interfere with ribosomal protein synthesis and with i...
Abstract: RNA is increasingly recognized for its signifi cant functions in biological systems and ha...
AbstractBackground: Aminoglycoside antibiotics bind to the A-site of the decoding region of 16S RNA ...
AbstractAminoglycoside antibiotics inhibit protein biosynthesis and various ribozymes. Structural el...
A variety of drugs inhibit biological key processes by binding to a speci®c RNA component. We focus ...
AbstractBackground: Aminoglycoside antibiotics interfere with ribosomal protein synthesis and with i...
AbstractAminoglycoside antibiotics inhibit protein biosynthesis and various ribozymes. Structural el...
The increased awareness of the central role of RNA has led to realization that RNA, as structural an...
AbstractBackground: Aminoglycoside antibiotics can target RNA folds with micromolar affinity and inh...
The codon-anticodon interaction on the ribosome occurs in the A site of the 30 S subunit. Aminoglyco...
Abstract Aminoglycoside antibiotics are protein synthesis inhibitors applied to treat infections cau...
Jury : Pr Bernard EHRESMANN (Président et examinateur), Dr Jean-Pierre GUILLOTEAU (Rapporteur extern...
AbstractBackground: Aminoglycoside antibiotics bind to the A-site of the decoding region of 16S RNA ...
AbstractBackground: Aminoglycoside antibiotics can target RNA folds with micromolar affinity and inh...